000			02134 a2200589 4500
005			20250513234253.0
264		0	_c20010913
008			200109s 0 0 eng d
022			_a1084-9785
024	7		_a10.1089/108497801750095989 _2doi
040			_aNLM _beng _cNLM
100	1		_aWilliams, L E
245	0	0	_aNumerical selection of optimal tumor imaging agents with application to engineered antibodies. _h[electronic resource]
260			_bCancer biotherapy & radiopharmaceuticals _cFeb 2001
300			_a25-35 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntibodies, Monoclonal _xchemistry
650	0	4	_aAntibodies, Neoplasm _xchemistry
650	0	4	_aAntibody Affinity
650	0	4	_aAntigen-Antibody Reactions
650	0	4	_aAntigens, Neoplasm _ximmunology
650	0	4	_aCarcinoembryonic Antigen _ximmunology
650	0	4	_aColorectal Neoplasms _xdiagnostic imaging
650	0	4	_aDrug Design
650	0	4	_aFemale
650	0	4	_aFluorine Radioisotopes _xpharmacokinetics
650	0	4	_aHumans
650	0	4	_aImmunoglobulin Fab Fragments _xchemistry
650	0	4	_aImmunoglobulin Fragments _xchemistry
650	0	4	_aImmunoglobulin G _xchemistry
650	0	4	_aIodine Radioisotopes _xpharmacokinetics
650	0	4	_aMice
650	0	4	_aMolecular Weight
650	0	4	_aNeoplasm Transplantation
650	0	4	_aNeoplasms _xdiagnostic imaging
650	0	4	_aProtein Engineering
650	0	4	_aRadioimmunodetection
650	0	4	_aRadiopharmaceuticals _xpharmacokinetics
650	0	4	_aRecombinant Fusion Proteins _xchemistry
650	0	4	_aTissue Distribution
650	0	4	_aTransplantation, Heterologous
650	0	4	_aTumor Cells, Cultured _xpathology
700	1		_aWu, A M
700	1		_aYazaki, P J
700	1		_aLiu, A
700	1		_aRaubitschek, A A
700	1		_aShively, J E
700	1		_aWong, J Y
773	0		_tCancer biotherapy & radiopharmaceuticals _gvol. 16 _gno. 1 _gp. 25-35
856	4	0	_uhttps://doi.org/10.1089/108497801750095989 _zAvailable from publisher's website
999			_c11215514 _d11215514